Questions: Basal Ganglia: Action Selection and Motor Planning

Question 1

The primary mechanism by which the basal ganglia enable voluntary movement is:

• A. Directly exciting motor cortex neurons to generate a movement command
• B. Releasing acetylcholine into the striatum to trigger specific motor programs
• C. Disinhibiting the thalamus by reducing the tonic inhibitory output of GPi and SNr
• D. Bypassing the thalamus to send motor commands directly to the spinal cord

Answer: (C)

The basal ganglia are a *gating* system, not a movement generator. At rest, GPi and SNr fire tonically at high rates, constantly inhibiting the thalamus and preventing motor cortex activation. To permit movement, the direct pathway (cortex → striatum → GPi/SNr) inhibits these output nuclei via GABA, releasing the thalamus from suppression — a double-negative that yields facilitation. This is disinhibition, not direct excitation. The basal ganglia do not generate movement commands; they selectively remove the brake on the desired motor program.

Question 2

A patient loses dopaminergic neurons in the substantia nigra pars compacta. Based on the direct/indirect pathway model, which explanation best accounts for the resulting bradykinesia (slowness of movement)?

• A. Dopamine directly excites motor cortex neurons; losing it weakens the cortical drive to move
• B. Without dopamine, the indirect pathway becomes relatively dominant, increasing tonic inhibition of the thalamus and making it harder to initiate movement
• C. Dopamine normally inhibits GPi directly; without it, GPi becomes so active it directly blocks muscle contraction
• D. Loss of dopamine causes the striatum to stop receiving cortical inputs entirely

Answer: (B)

Dopamine has opposite effects on the two pathways: it excites direct-pathway striatal neurons (D1 receptors) and inhibits indirect-pathway striatal neurons (D2 receptors). The net effect is to facilitate movement by promoting the 'go' signal and suppressing the 'stop' signal. Without dopamine, the indirect pathway's braking influence goes unchecked while the direct pathway's facilitating influence is weakened. The result is excessive tonic inhibition of the thalamus — movement is suppressed rather than selectively gated, producing the rigidity and bradykinesia of Parkinson's disease.

Question 3

At rest, the output nuclei of the basal ganglia (GPi and SNr) are largely silent, which allows the thalamus to freely activate motor cortex.

• T. True
• F. False

Answer: False

This is precisely backwards. At rest, GPi and SNr fire tonically at HIGH rates — they are among the most active neurons in the brain at baseline. This constant inhibitory output keeps the thalamus suppressed, which prevents motor cortex activation and thus prevents movement. Voluntary movement requires an active process of *reducing* this tonic inhibition via the direct pathway. The basal ganglia's default state is 'brake applied'; movement requires releasing the brake on the desired motor program while keeping brakes applied to everything else.

Question 4

Dopamine promotes voluntary movement by simultaneously facilitating the direct (movement-facilitating) pathway and inhibiting the indirect (movement-suppressing) pathway in the striatum.

• T. True
• F. False

Answer: True

This dual action is the elegant design of the dopaminergic modulation. Direct-pathway striatal neurons express D1 receptors and are excited by dopamine; indirect-pathway striatal neurons express D2 receptors and are inhibited by dopamine. Stimulating D1 increases the 'go' signal to the thalamus; inhibiting D2 reduces the 'stop' signal. The two effects are synergistic: together they shift the balance decisively toward action initiation. This explains why D1 and D2 receptor pharmacology is so important in treating both Parkinson's disease and dopamine-excess conditions like dyskinesias.

Question 5

Why is Parkinson's disease best understood as a problem of excessive inhibition rather than a simple loss of motor drive, and what happens to the balance of direct and indirect pathways when dopamine is depleted?

Model answer: In Parkinson's disease, the loss of dopaminergic neurons in the substantia nigra pars compacta disrupts the balance between the basal ganglia's two pathways. Without dopamine: the direct pathway (which inhibits GPi/SNr and releases the thalamus) is weakened, and the indirect pathway (which ultimately excites GPi/SNr and strengthens thalamic suppression) is disinhibited. The net result is that GPi/SNr fire excessively, imposing too much inhibition on the thalamus, which cannot adequately activate motor cortex. Patients cannot easily initiate or sustain movement not because the motor cortex or muscles are weak, but because the brake is stuck on — the gating system defaults to suppression.

Understanding Parkinson's as a gating failure rather than a motor weakness explains why treatments (dopamine precursors like L-DOPA, D2 antagonists, deep brain stimulation of STN) target the basal ganglia circuit rather than the motor cortex or neuromuscular junction. It also explains why dyskinesias (excess involuntary movements) can be a side effect of too much dopamine replacement — the gate swings too far the other way.